Pages that link to "Q48579052"
Jump to navigation
Jump to search
The following pages link to Pathophysiology of dystonia (Q48579052):
Displaying 31 items.
- Mutations in the autoregulatory domain of β-tubulin 4a cause hereditary dystonia (Q24605412) (← links)
- Movement Disorders Following Cerebrovascular Lesion in the Basal Ganglia Circuit (Q26744786) (← links)
- Activity and topographic changes in the somatosensory system in embouchure dystonia (Q30571216) (← links)
- Convergent evidence for abnormal striatal synaptic plasticity in dystonia (Q33756951) (← links)
- Botulinum toxin therapy for cervical dystonia: the science of dosing (Q34518731) (← links)
- Abnormal movement preparation in task-specific focal hand dystonia (Q35027873) (← links)
- A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins (Q35681898) (← links)
- Alternative approaches to modeling hereditary dystonias (Q35913791) (← links)
- Deep brain stimulation suppresses pallidal low frequency activity in patients with phasic dystonic movements (Q36745301) (← links)
- Fractional anisotropy in children with dystonia or spasticity correlates with the selection for DBS or ITB movement disorder surgery. (Q36762395) (← links)
- Sonographic Alteration of Basal Ganglia in Different Forms of Primary Focal Dystonia: A Cross-sectional Study (Q36797812) (← links)
- The mechanisms of movement control and time estimation in cervical dystonia patients (Q37250886) (← links)
- DYT6 dystonia: review of the literature and creation of the UMD Locus-Specific Database (LSDB) for mutations in the THAP1 gene (Q37906497) (← links)
- Treatment for dystonia in childhood (Q37979912) (← links)
- Dopamine-dependent reinforcement of motor skill learning: evidence from Gilles de la Tourette syndrome (Q39732542) (← links)
- Cortico-pallidal oscillatory connectivity in patients with dystonia. (Q40983983) (← links)
- Globus pallidus interna deep brain stimulation in a patient with medically intractable meige syndrome (Q41977706) (← links)
- White matter abnormalities in gene-positive myoclonus-dystonia (Q42515181) (← links)
- Disrupted superior collicular activity may reveal cervical dystonia disease pathomechanisms. (Q47165104) (← links)
- Disruption in cerebellar and basal ganglia networks during a visuospatial task in cervical dystonia (Q47992866) (← links)
- The clinical phenomenology and associations of trick maneuvers in cervical dystonia (Q48044816) (← links)
- Outcomes of Onabotulinum Toxin A Treatment for Adductor Spasmodic Dysphonia and Laryngeal Tremor (Q50104354) (← links)
- Different clinical course of pallidal deep brain stimulation for phasic- and tonic-type cervical dystonia (Q52145833) (← links)
- Benefits of pallidal stimulation in dystonia are linked to cerebellar volume and cortical inhibition (Q59328870) (← links)
- Risk Factor Genes in Patients with Dystonia: A Comprehensive Review (Q60915109) (← links)
- Fatigue, Sleep Disturbances, and Their Influence on Quality of Life in Cervical Dystonia Patients (Q63952360) (← links)
- Deep brain stimulation: current challenges and future directions (Q63976384) (← links)
- Severity of dystonia is correlated with putaminal gray matter changes in Myoclonus-Dystonia (Q83186332) (← links)
- Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study (Q89414181) (← links)
- Predictive factors of outcome in cervical dystonia following deep brain stimulation: an individual patient data meta-analysis (Q90096530) (← links)
- Defining differences in patient characteristics between spasmodic dysphonia and laryngeal tremor (Q93063596) (← links)